Correlation Between Memphis Pharmaceuticals and Saudi Egyptian

Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Saudi Egyptian at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Saudi Egyptian into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Memphis Pharmaceuticals and Saudi Egyptian Investment, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Saudi Egyptian and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Saudi Egyptian. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Saudi Egyptian.

Diversification Opportunities for Memphis Pharmaceuticals and Saudi Egyptian

0.45

Correlation Coefficient

Memphis Pharmaceuticals  Saudi Egyptian

Very weak diversification

The 3 months correlation between Memphis and Saudi is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Saudi Egyptian Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Saudi Egyptian Investment and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Saudi Egyptian. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Saudi Egyptian Investment has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Saudi Egyptian go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Saudi Egyptian

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to under-perform the Saudi Egyptian. In addition to that, Memphis Pharmaceuticals is 8.47 times more volatile than Saudi Egyptian Investment. It trades about -0.12 of its total potential returns per unit of risk. Saudi Egyptian Investment is currently generating about 0.24 per unit of volatility. If you would invest  6,356  in Saudi Egyptian Investment on September 26, 2024 and sell it today you would earn a total of  126.00  from holding Saudi Egyptian Investment or generate 1.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Memphis Pharmaceuticals  vs.  Saudi Egyptian Investment

Memphis Pharmaceuticals

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Saudi Egyptian Investment

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Saudi Egyptian Investment are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Saudi Egyptian is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Memphis Pharmaceuticals and Saudi Egyptian

The main advantage of trading using opposite Memphis Pharmaceuticals and Saudi Egyptian positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Saudi Egyptian can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Saudi Egyptian will offset losses from the drop in Saudi Egyptian's long position.

The idea behind Memphis Pharmaceuticals and Saudi Egyptian Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.